Indiana Trust & Investment Management CO Eli Lilly & CO Transaction History

Indiana Trust & Investment Management CO

$290 Million
Q3 2024

A detailed history of Indiana Trust & Investment Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Indiana Trust & Investment Management CO holds 11,825 shares of LLY stock, worth $9.26 Million. This represents 3.62% of its overall portfolio holdings.

Number of Shares

11,825

Previous 17,102 30.86%

Holding current value

$9.26 Million

Previous $15.5 Million 32.34%

% of portfolio

3.62%

Previous 5.73%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $4.07 Million - $5.07 Million	-5,277 Reduced 30.86%	11,825 $10.5 Million
Q2 2024 Jul 10, 2024	BUY	$724.87 - $909.04 $523,356 - $656,326	722 Added 4.41%	17,102 $15.5 Million
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $521,136 - $697,206	880 Added 5.68%	16,380 $12.7 Million
Q4 2023 Jan 23, 2024	BUY	$525.19 - $619.13 $409,648 - $482,921	780 Added 5.3%	15,500 $9.04 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $184,747 - $254,702	425 Added 2.97%	14,720 $7.91 Million
Q2 2023 Jul 07, 2023	BUY	$350.74 - $468.98 $31,566 - $42,208	90 Added 0.63%	14,295 $6.7 Million
Q1 2023 Apr 06, 2023	SELL	$310.63 - $364.82 $15,220 - $17,876	-49 Reduced 0.34%	14,205 $4.88 Million
Q4 2022 Jan 09, 2023	BUY	$321.55 - $374.67 $89,069 - $103,783	277 Added 1.98%	14,254 $5.21 Million
Q3 2022 Oct 11, 2022	BUY	$296.48 - $337.87 $72,637 - $82,778	245 Added 1.78%	13,977 $4.52 Million
Q2 2022 Jul 08, 2022	SELL	$278.73 - $327.27 $56,303 - $66,108	-202 Reduced 1.45%	13,732 $4.45 Million
Q1 2022 Apr 04, 2022	BUY	$234.69 - $291.66 $24,407 - $30,332	104 Added 0.75%	13,934 $3.99 Million
Q4 2021 Jan 10, 2022	SELL	$224.85 - $279.04 $23,609 - $29,299	-105 Reduced 0.75%	13,830 $3.82 Million
Q3 2021 Oct 04, 2021	SELL	$221.6 - $272.71 $670,783 - $825,493	-3,027 Reduced 17.85%	13,935 $3.22 Million
Q2 2021 Jul 07, 2021	BUY	$180.55 - $233.54 $83,414 - $107,895	462 Added 2.8%	16,962 $2.86 Million
Q1 2021 Apr 06, 2021	SELL	$164.32 - $212.72 $75,915 - $98,276	-462 Reduced 2.72%	16,500 $3.08 Million
Q4 2020 Jan 07, 2021	SELL	$130.46 - $172.63 $111,934 - $148,116	-858 Reduced 4.81%	16,962 $2.86 Million
Q3 2020 Oct 06, 2020	BUY	$146.22 - $169.13 $283,228 - $327,604	1,937 Added 12.2%	17,820 $2.64 Million
Q2 2020 Jul 14, 2020	BUY	$136.42 - $164.18 $19,098 - $22,985	140 Added 0.89%	15,883 $2.61 Million
Q1 2020 Apr 06, 2020	BUY	$119.05 - $147.35 $1,666 - $2,062	14 Added 0.09%	15,743 $2.18 Million
Q4 2019 Jan 13, 2020	SELL	$106.92 - $132.43 $8,125 - $10,064	-76 Reduced 0.48%	15,729 $2.07 Million
Q3 2019 Oct 04, 2019	SELL	$106.79 - $116.16 $81,160 - $88,281	-760 Reduced 4.59%	15,805 $1.77 Million
Q2 2019 Jul 10, 2019	SELL	$110.79 - $129.32 $13,848 - $16,165	-125 Reduced 0.75%	16,565 $1.84 Million
Q1 2019 Apr 08, 2019	BUY	$111.31 - $131.02 $731,195 - $860,670	6,569 Added 64.9%	16,690 $2.17 Million
Q4 2018 Jan 07, 2019	SELL	$105.9 - $118.64 $16,626 - $18,626	-157 Reduced 1.53%	10,121 $1.17 Million
Q3 2018 Oct 11, 2018	SELL	$85.86 - $107.31 $9,015 - $11,267	-105 Reduced 1.01%	10,278 $1.1 Million
Q2 2018 Jul 06, 2018	SELL	$75.7 - $86.88 $121,422 - $139,355	-1,604 Reduced 13.38%	10,383 $886,000
Q1 2018 Apr 09, 2018	BUY	$74.21 - $87.6 $83,857 - $98,988	1,130 Added 10.41%	11,987 $927,000
Q4 2017 Jan 12, 2018	BUY	$81.94 - $87.89 $62,274 - $66,796	760 Added 7.53%	10,857 $917,000
Q3 2017 Oct 05, 2017	BUY	$77.07 - $85.54 $778,175 - $863,697	10,097	10,097 $864,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Indiana Trust & Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Indiana Trust & Investment Management CO with notifications on news.

Account

Indiana Trust & Investment Management CO Eli Lilly & CO Transaction History